Lilly To Inject $1B In New Manufacturing Facility In North Carolina, US

Eli Lilly And Co LLY plans to invest over $1 billion to create a new manufacturing site in the U.S, with nearly 600 new jobs in Concord, North Carolina. 

• The new facility will manufacture parenteral (injectable) products and devices and increase the company's manufacturing capacity. 
• In 2020, Lilly announced a $470 million investment in North Carolina's Research Triangle Park. 
• In addition, an estimated 500 additional positions will be required while the facility is under construction.
• Over the last five years, Lilly has invested over $4 billion in global manufacturing, including more than $2 billion in the U.S. 
• The company announced plans to invest $500 million in a new biopharmaceutical manufacturing facility in Limerick, Ireland. 
• Lilly anticipates additional future investments in manufacturing to address growth expected from potential new medicines to treat diabetes, Alzheimer's disease, cancer, and autoimmune conditions.
• Price Action: LLY shares up 1.86% at $241.13 during the market session on the last check Friday.